Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619
This examiner grants 45% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19300145 | DURABLE ANTI-FUNGAL AND ALGAE RESISTANT COATINGS | Non-Final OA | MICROBAN PRODUCTS COMPANY |
| 16623591 | COSMETIC COMPOSITION COMPRISING TWO SPECIFIC CATIONIC SURFACTANTS AND A SILICONE EMULSION, AND A COSMETIC TREATMENT PROCESS | Non-Final OA | L'OREAL |
| 18332101 | NON-VIRAL DELIVERY OF SMALL MOLECULE THERAPEUTICS | Final Rejection | BATTELLE MEMORIAL INSTITUTE |
| 17535062 | PHENYLALANINE FUNCTIONALISED MESOPOROUS SILICA NANOPARTICLES AS DRUG-FREE NANOTHERAPEUTICS OR BIOACTIVE NANOCARRIER FOR ANTI-CANCER APPLICATIONS | Final Rejection | Nanyang Technological University |
| 18784354 | TREATMENT OF LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER WITH A THERMALLY GELLING PHARMACEUTICAL COMPOSITION CONTAINING MITOMYCIN | Non-Final OA | UROGEN PHARMA LTD. |
| 17967267 | Microemulsion Delivery Systems for A Female Hormone Blend with Alcohol-Soluble Species Including Nonderivatized Hormones | Non-Final OA | Quicksilver Scientific, Inc. |
| 17672894 | Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones | Non-Final OA | Quicksilver Scientific, Inc. |
| 17370101 | DECELLULARIZATION OF TISSUES USING SUPERCRITICAL CARBON DIOXIDE | Final Rejection | UNIVERSITY OF SOUTH CAROLINA |
| 16785549 | SEMI-PERMANENT TATTOOS | Non-Final OA | inkbox ink incorporated |
| 18496799 | PROTEIN FUNCTIONALIZED HYALURONIC ACID COATED CHITOSAN NANOPARTICLE AND METHOD OF PREPARATION | Final Rejection | KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY |
| 17790805 | NITRAPYRIN COMPOSITIONS FOR ENHANCING NITROGEN NUTRIENT USE EFFICIENCY AND IMPROVING PLANT GROWTH | Final Rejection | Verdesian Life Sciences U.S., LLC |
| 17369620 | COMPOSITIONS AND METHODS TO DISINFECT, TREAT AND PREVENT MICROBIAL INFECTIONS | Non-Final OA | WIAB WATER INNOVATION AB |
| 17869477 | POLYMER-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | Final Rejection | eXion labs Inc. |
| 17589422 | ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES | Final Rejection | ChromaDex Inc. |
| 17408945 | Low-Dose Doxepin Formulations And Methods Of Making And Using The Same | Non-Final OA | Currax Pharmaceuticals LLC |
| 17345059 | C3-C5 N-ALKYL-GAMMA-BUTYROLACTAM-CONTAINING ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | Non-Final OA | Virox Technologies Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy